TRENDING :  Market Movers  |  Top 50   FDX (2.24%)    AMZN (1.23%)    SPY (1.13%)    TAC (-0.59%)    TARO (0.26%)    TJX (-0.1%)    TSLA (0.16%)    UNIT (2%)    UTX (1.26%)    VXXB (-1.31%)    WYNN (2.54%)    XLU (1.07%)    XPER (1.68%)    ZUO (2.49%)    AAPL (3.69%)    ADSK (2.93%)    AMAT (4.45%)    BA (-0.92%)    BIIB (-29.24%)    BRS (-9.03%)    CFMS (-5.82%)    CLRB (1.66%)    CVRS (-22.69%)    CZZ (1.17%)    DIS (-1.21%)

CGC - Canopy Growth Corporation

$46.04 [-0.83][-1.78%]

Next Earnings



Trade Idea »


Quarterly Rating Chart


1=Strong Buy, 2=Buy, 3=Hold, 4=Underperform, 5=Sell
Price Targets
High $60.00
Low $40.00
Average $50.00
Current $46.04

CompanyAnalyst NamePT ActionActionRatingTargetDate
PiperJaffrayRaisesReiteratesStrong Buy$60.0001/25/19
PiperJaffrayAnnouncesInitiates Coverage OnStrong Buy$40.0001/09/19
*Last 90 days


No recommendations found.

This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.



HEXO's Acquisition Shakes Up the Top 11 Marijuana Growers List

If you re looking for one of the fastest growing industries on the planet you ve found it with legal marijuana It has generated less than 10 billion in annual sales worldwide in 2017 but investment bank Cowen Group is calling for up to 75 billion in global sales by 2030

Who’s Made The Right Call On Cronos Group Stock? Altria or Analysts?

InvestorPlace Stock Market News Stock Advice amp Trading Tips So far 2019 has been good to Cronos Group NASDAQ CRON Its share price has more than doubled this year And the CRON stock gains make some sense Indeed as I wrote in December the 1

Mannatech, Incorporated (MTEX) Ex-Dividend Date Scheduled for March 21, 2019

Mannatech Incorporated MTEX will begin trading ex dividend on March 21 2019 A cash dividend payment of 0 125 per share is scheduled to be paid on March 29 2019 Shareholders who purchased MTEX prior to the ex dividend date are eligible for the cash dividend payment This represents

Tilray: No Sane Investor Can Justify Its $7 Billion Valuation Following Its Fourth-Quarter Results

On Monday following the closing bell Canadian cannabis grower Tilray NASDAQ TLRY released its much anticipated fourth quarter and full year operating results With Canada officially legalizing recreational marijuana on Oct 17 2018 Wall Street and investors were

4 Things Tilray Should Have Revealed in Its Q4 Update But Didn't

Tilray NASDAQ TLRY announced its fourth quarter results after the market closed on Monday As expected the Canadian marijuana producer reported strong sales growth Also as expected Tilray posted a substantial net loss Investors seemed to like what they saw in Tilray

Tilray: 7 Facts About This Marijuana Stock's Quarterly Performance

Canadians spend about 6 billion per year on marijuana and until recently most of that spending has been done in the shadows However Canada s recreational adult use market opened for business last October so billions of dollars could shift from the black market to publicly

Tilray Lags Behind Its Marijuana Peers

The competition among marijuana stocks has been fierce in recent months as the big rebound in share prices across the cannabis industry has reflected growing optimism about the fundamental prospects for the business as a whole Tilray NASDAQ TLRY has a market capitalization

Buy Marijuana Stocks Now? You'd Have to Be Stoned.

Marijuana stocks have become the next big thing Thirty three states have legalized medical marijuana including 10 and the District of Columbia that have greenlighted it for recreational use In Maryland where I live medical marijuana dispensaries are opening apace and several clients

Profit from Cannabis with Canopy Growth and Scotts Miracle-Gro

InvestorPlace Stock Market News Stock Advice amp Trading Tips Do you want to grow your trading account Then it may be high time to look at cannabis leaders Canopy Growth Corp NYSE CGC and Scotts Miracle Gro NYSE SMG Across all lines of business a strong blend

Why Tilray Stock Is Still Worth a Look Despite Earnings Flop

InvestorPlace Stock Market News Stock Advice amp Trading Tips We often hear jokes about the lofty valuations of cannabis stocks They have huge market capitalizations with only a tiny fraction of them in actual revenues Tilray 160 NASDAQ TLRY is perhaps the poster child

The Importance Of Being Nimble In Cannabis Investing With Saul Kaye (Podcast)

By The Cannabis Investing Podcast ByThe Cannabis Investing Podcast The cannabis sector is a nascent industry where changes are happening quickly around regulations laws medical and production innovation all of which affects what stocks may or may not prosper With this in mind we

The 3 Most Important Takeaways From Tilray's Quarterly Results

The meteoric surge higher last year in Tilray s NASDAQ TLRY shares put this Canadian marijuana stock on investors radars but it hasn t been all good news for shareholders Its stock price has dropped 75 from its peak of 300 last fall Can this cannabis company compete with

Why Tilray Stock’s Q4 Report Shouldn’t Be About Q4 Numbers

InvestorPlace Stock Market News Stock Advice amp Trading Tips The ongoing cannabis stock craze will likely see another move after Monday s closing bell That s when Canadian pot conglomerate Tilray NASDAQ TLRY is slated to report its fourth quarter numbers perhaps

2 Brand-Name Pot Stocks That Will Lose Money in 2020

Investors would struggle to find an industry that s growing at a faster and more consistent pace than the legal marijuana industry According to an annual report from Arcview Market Research and BDS Analytics global cannabis sales are set to rise from less than 10 billion in 2017 to

3 Reasons Legal Weed Sales Aren't Getting Any Higher in Canada

According to Health Canada licensed businesses sold 7 115 kilograms of dried flower in January That was 3 7 less than in December which hardly looks like a Canadian sales explosion that will help Aurora Cannabis NYSE ACB or Cronos Group NASDAQ CRON make ends meet